Thanks for that. Okay, you're right. On the 4C they disclose the footnote "All commissioning and production ramp-up costs incurred at Balama, net of any revenue derived from the sale of graphite, prior to the declaration of commercial production are capitalised against project development costs." This net number is an outflow of US$15.2m.
I'm not entirely sure this is a compliant 4C with this qualification. In any case, it would appear that Management are doing everything they can to obfuscate the average revenue per tonnes. They give a range of sales between US$375-USD$1700, which, frankly, is quite unhelpful. Revenues are accordingly somewhere between US$21m-$94m... that's a pretty big range.
- Forums
- ASX - By Stock
- Ann: September Quarterly Activities and Cashflow Report
Thanks for that. Okay, you're right. On the 4C they disclose the...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
22.5¢ | 23.0¢ | 21.5¢ | $1.244M | 5.635M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 116777 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 52000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 116062 | 1.070 |
10 | 209299 | 1.065 |
8 | 106613 | 1.060 |
6 | 96647 | 1.055 |
10 | 132219 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 58078 | 4 |
1.080 | 70753 | 4 |
1.085 | 72117 | 5 |
1.090 | 103210 | 6 |
1.095 | 57928 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online